Johnathan D. Ebben
Impact in
-
- Cancer Cells and Metastasis
-
- Glioma Diagnosis and Treatment
Papers in
- Oncology 4
- CAR-T cell therapy research 1
- Cancer Cells and Metastasis 1
- Lung Cancer Research Studies 1
-
- Immunotherapy and Immune Responses 2
- Immune Cell Function and Interaction 1
- Co-authors
- John S. Kuo (4 shared papers)Paul Alexander Clark (3 shared papers)Daniel M. Treisman (2 shared papers)Michael Zorniak (2 shared papers)Ming You (2 shared papers)Andreas Beyer (2 shared papers)Andrew O. Kadlec (1 shared paper)Ekram A. Gad (1 shared paper)
- Journals
- Drugs (1 paper)The International Journal of Biochemistry & Cell Biology (1 paper)Developmental Dynamics (1 paper)Pharmacological Research (1 paper)Expert Opinion on Therapeutic Targets (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
Johnathan D. Ebben
11 papers receiving 345 citations
Peers
Comparison fields: 5 of 70
- Oncology 121
- Genetics 41
- Cancer Research 50
- Aging 5
- Molecular Biology 181
Countries citing papers authored by Johnathan D. Ebben
This map shows the geographic impact of Johnathan D. Ebben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johnathan D. Ebben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johnathan D. Ebben more than expected).
Fields of papers citing papers by Johnathan D. Ebben
This network shows the impact of papers produced by Johnathan D. Ebben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johnathan D. Ebben. The network helps show where Johnathan D. Ebben may publish in the future.
Co-authors
The 25 scholars most cited alongside Johnathan D. Ebben, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 80 | |
| 2 | 2018 | 61 | |
| 3 | 2007 | 55 | |
| 4 | 2011 | 38 | |
| 5 | 2015 | 29 | |
| 6 | 2016 | 29 | |
| 7 | 2016 | 25 | |
| 8 | 2021 | 24 | |
| 9 | 2009 | 7 | |
| 10 | 2018 | 4 | |
| 11 | 2025 | 4 |
About Johnathan D. Ebben
Johnathan D. Ebben is a scholar working on Oncology, Immunology, Molecular Biology, Aging and Developmental Neuroscience, having authored 11 papers that have together received 356 indexed citations. Recurring topics across this work include vaccines and immunoinformatics approaches (2 papers), Immunotherapy and Immune Responses (2 papers), Immune Cell Function and Interaction (1 paper), CAR-T cell therapy research (1 paper), Cancer Cells and Metastasis (1 paper), Pluripotent Stem Cells Research (1 paper), Antimicrobial Peptides and Activities (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Oncology (121 citations), Genetics (41 citations), Cancer Research (50 citations), Aging (5 citations) and Molecular Biology (181 citations). Johnathan D. Ebben has collaborated with scholars based in United States and China. Frequent co-authors include John S. Kuo, Paul Alexander Clark, Daniel M. Treisman, Michael Zorniak, Ming You, Andreas Beyer, Andrew O. Kadlec, Ekram A. Gad, Karima Ait‐Aissa and Ronald A. Lubet. Their work appears in journals such as Drugs, The International Journal of Biochemistry & Cell Biology, Developmental Dynamics, Pharmacological Research and Expert Opinion on Therapeutic Targets.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.